We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Smoking deal

28 October 2003

The $6.3bn merger of its US operations with RJR has multiple benefits. But the biggest prize may lie in convincing investors that US litigation is no longer a threat. That could spark a rerating of the stock.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)